Global Regenerative Medicines Market Research Report 2021

 Table of Contents


Global Regenerative Medicines Market Research Report 2021
1 Regenerative Medicines Overview
    1.1 Product Overview and Scope of Regenerative Medicines
    1.2 Regenerative Medicines Segment by Types
        1.2.1 Global Sales Market Share of Regenerative Medicines by Type in 2015
        1.2.2 Cell Therapy
        1.2.3 Gene Therapy
        1.2.4 Immunotherapy
        1.2.5 Tissue Engineering
    1.3 Regenerative Medicines Segment by Applications
        1.3.1 Department of orthopedics and musculoskeletal spine
        1.3.2 Skin disease
        1.3.3 Cardiovascular
        1.3.4 Central nervous system
        1.3.5 Oncology
        1.3.6 Diabetes
    1.4 Regenerative Medicines Market by Regions
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 China Status and Prospect (2011-2021)
        1.4.3 Europe Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 India Status and Prospect (2011-2021)
        1.4.6 Southeast Asia Status and Prospect (2011-2021)
    1.5 Global Market Size (Value and Volume) of Regenerative Medicines (2011-2021)
        1.5.1 Global Regenerative Medicines Sales and Revenue (2011-2021)
        1.5.2 Global Regenerative Medicines Sales and Growth Rate (2011-2021)
        1.5.3 Global Regenerative Medicines Revenue and Growth Rate (2011-2021)

2 Global Regenerative Medicines Market Competition by Manufacturers
    2.1 Global Regenerative Medicines Sales and Share by Manufacturers (2015 and 2016)
    2.2 Global Regenerative Medicines Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Manufacturers Regenerative Medicines Manufacturing Base Distribution and Product Type
    2.4 Competitive Situation and Trends
        2.4.1 Expansions
        2.4.2 New Product Launches
        2.4.3 Acquisitions
        2.4.4 Other Developments

3 Global Regenerative Medicines Analysis by Region
    3.1 Global Regenerative Medicines Sales, Revenue and Market Share by Region (2011-2021)
        3.1.1 Global Regenerative Medicines Sales Market Share by Region (2011-2021)
        3.1.2 Global Regenerative Medicines Revenue Market Share by Region (2011-2021)
    3.2 North America
        3.2.1 North America Regenerative Medicines Sales, Revenue and Price (2011-2021)
        3.2.2 North America Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
    3.3 Europe
        3.3.1 Europe Regenerative Medicines Sales, Revenue and Price (2011-2021)
        3.3.2 Europe Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
    3.4 China
        3.4.1 China Regenerative Medicines Sales, Revenue and Price (2011-2021)
        3.4.2 China Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
    3.5 Japan
        3.5.1 Japan Regenerative Medicines Sales, Revenue and Price (2011-2021)
        3.5.2 Japan Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
    3.6 India
        3.6.1 India Regenerative Medicines Sales, Revenue and Price (2011-2021)
        3.6.2 India Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
    3.7 Southeast Asia
        3.7.1 Southeast Asia Regenerative Medicines Sales, Revenue and Price (2011-2021)
        3.7.2 Southeast Asia Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)

4 Global Regenerative Medicines Analysis by Type
    4.1 Global Regenerative Medicines Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
        4.1.1 Global Regenerative Medicines Sales and Market Share by Type (2011-2021)
        4.1.2 Global Regenerative Medicines Revenue, Market Share and Growth Rate by Type (2011-2021)
    4.2 Cell Therapy Sales, Revenue, Price and Growth (2011-2021)
    4.3 Gene Therapy Sales, Revenue, Price and Growth (2011-2021)
    4.4 Immunotherapy Sales, Revenue, Price and Growth (2011-2021)
    4.5 Tissue Engineering Sales, Revenue, Price and Growth (2011-2021)

5 Global Regenerative Medicines Market Analysis by Application
    5.1 Global Regenerative Medicines Sales and Market Share by Application (2011-2021)
    5.2 Major Regions Regenerative Medicines Sales by Application in 2015 and 2016
        5.2.1 North America Regenerative Medicines Sales by Application
        5.2.2 Europe Regenerative Medicines Sales by Application
        5.2.3 China Regenerative Medicines Sales by Application
        5.2.4 Japan Regenerative Medicines Sales by Application
        5.2.5 India Regenerative Medicines Sales by Application
        5.2.6 Southeast Asia Regenerative Medicines Sales by Application

6 Global Regenerative Medicines Manufacturers Analysis
    6.1 Celgene Corporation (U.S.)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Regenerative Medicines Product Overview
            6.1.2.1 Cell Therapy
            6.1.2.2 Gene Therapy
            6.1.2.3 Immunotherapy
        6.1.3 Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)
    6.2 StemCells, Inc. (U.S.)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Regenerative Medicines Product Overview
            6.2.2.1 Cell Therapy
            6.2.2.2 Gene Therapy
            6.2.2.3 Immunotherapy
        6.2.3 Regenerative Medicines Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)
    6.3 Corning Incorporated (U.S.)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Regenerative Medicines Product Overview
            6.3.2.1 Cell Therapy
            6.3.2.2 Gene Therapy
            6.3.2.3 Immunotherapy
        6.3.3 Regenerative Medicines Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)
    6.4 Organogenesis Inc. (U.S.)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Regenerative Medicines Product Overview
            6.4.2.1 Cell Therapy
            6.4.2.2 Gene Therapy
        6.4.3 Regenerative Medicines Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)
    6.5 Acelity (KCI Licensing) (U.S.)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Regenerative Medicines Product Overview
            6.5.2.1 Cell Therapy
            6.5.2.2 Gene Therapy
        6.5.3 Regenerative Medicines Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)
    6.6 Vertex Pharmaceuticals Incorporated (U.S.)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Regenerative Medicines Product Overview
            6.6.2.1 Cell Therapy
            6.6.2.2 Gene Therapy
        6.6.3 Regenerative Medicines Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)
    

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures


Figure Picture of Regenerative Medicines
Figure Global Sales Market Share of Regenerative Medicines by Type in 2015
Table Regenerative Medicines Product Type of by Manufacturers
Table Regenerative Medicines Sales Market Share by Application in 2015 and 2016
Figure North America Regenerative Medicines Revenue and Growth Rate (2011-2021)
Figure China Regenerative Medicines Revenue and Growth Rate (2011-2021)
Figure Europe Regenerative Medicines Revenue and Growth Rate (2011-2021)
Figure Japan Regenerative Medicines Revenue and Growth Rate (2011-2021)
Figure India Regenerative Medicines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Regenerative Medicines Revenue and Growth Rate (2011-2021)
Table Global Regenerative Medicines Sales and Revenue (2011-2021)
Figure Global Regenerative Medicines Sales and Growth Rate (2011-2021)
Figure Global Regenerative Medicines Revenue and Growth Rate (2011-2021)
Table Global Regenerative Medicines Sales of Key Manufacturers (2015 and 2016)
Table Global Regenerative Medicines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Regenerative Medicines Sales Share by Manufacturers
Figure 2016 Regenerative Medicines Sales Share by Manufacturers
Table Global Regenerative Medicines Revenue by Manufacturers (2015 and 2016)
Table Global Regenerative Medicines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Regenerative Medicines Revenue Share by Manufacturers
Table 2016 Global Regenerative Medicines Revenue Share by Manufacturers
Table Manufacturers Regenerative Medicines Manufacturing Base Distribution and Product Type
Table Global Regenerative Medicines Sales Market by Region (2011-2021)
Figure Global Regenerative Medicines Sales Market by Region (2011-2021)
Figure Global Regenerative Medicines Sales Market Share by Region (2011-2021)
Table Global Regenerative Medicines Revenue Market by Region (2011-2021)
Table Global Regenerative Medicines Revenue Market Share by Region (2011-2021)
Table North America Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure North America Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
Table Europe Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure Europe Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
Table China Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure China Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
Table Japan Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure Japan Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
Table India Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure India Regenerative Medicines Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Regenerative Medicines Sales, Revenue and Growth Rate  (2011-2021)
Table Global Regenerative Medicines Sales by Type (2011-2021)
Table Global Regenerative Medicines Sales Share by Type (2011-2021)
Figure Sales Market Share of Regenerative Medicines by Type (2011-2021)
Figure Global Regenerative Medicines Sales Growth Rate by Type (2011-2021)
Table Global Regenerative Medicines Revenue by Type (2011-2021)
Table Global Regenerative Medicines Revenue Share by Type (2011-2021)
Figure Global Regenerative Medicines Revenue Growth Rate by Type (2011-2021)
Figure Cell Therapy Sales, Revenue and Growth (2011-2021)
Figure Cell Therapy Price Trend (2011-2021)
Figure Gene Therapy Sales, Revenue and Growth (2011-2021)
Figure Gene Therapy Price Trend (2011-2021)
Figure Immunotherapy Sales, Revenue and Growth (2011-2021)
Figure Immunotherapy Price Trend (2011-2021)
Figure Tissue Engineering Sales, Revenue and Growth (2011-2021)
Figure Tissue Engineering Price Trend (2011-2021)
Table Global Regenerative Medicines Sales by Application (2011-2021)
Table Global Regenerative Medicines Sales Market Share by Application (2011-2021)
Figure Global Regenerative Medicines Sales Market Share by Application in 2015
Figure Global Regenerative Medicines Sales Market Share by Application in 2021
Table North America Regenerative Medicines Sales by Application (2015 and 2016)
Table Europe Regenerative Medicines Sales by Application (2015 and 2016)
Table China Regenerative Medicines Sales by Application (2015 and 2016)
Table Japan Regenerative Medicines Sales by Application (2015 and 2016)
Table India Regenerative Medicines Sales by Application (2015 and 2016)
Table Southeast Asia Regenerative Medicines Sales by Application (2015 and 2016)
Table Global Regenerative Medicines Sales Growth Rate by Application (2011-2021)
Figure Global Regenerative Medicines Sales Growth Rate by Application (2011-2021)
Table Celgene Corporation (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)
Table StemCells, Inc. (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)
Table Corning Incorporated (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)
Table Organogenesis Inc. (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)
Table Acelity (KCI Licensing) (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)
Table Vertex Pharmaceuticals Incorporated (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)
 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy